Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
68 Cards in this Set
- Front
- Back
|
Abreva?
|
Doconasol: Topical Antiviral
FDA approved for treatment of HSL lesions on lips and face |
|
|
Alphagan?
|
Brimonidine: Opthalmic Alpha-2 Agonist.
|
|
|
MOA of Alphagan?
|
Alpha-2 agonism to decrease aqueous humor production
|
|
|
Alphagan dose?
|
1 drop tid
|
|
|
Anbesol?
|
Benzocaine
|
|
|
Clindamycin HCL Oral
|
Cleocin
|
|
|
Clindamycin Indications?
|
Anaerobes, streptococci, pneumococci, and staphylococci; bacterial vaginosis (vaginal cream, vaginal suppository); pelvic inflammatory disease (I.V.); topically in treatment of severe acne; vaginally for Gardnerella vaginalis
|
|
|
Clindamycin MOA?
|
Reversibly binds to 50S ribosomal subunits preventing peptide bond formation thus inhibiting bacterial protein synthesis
|
|
|
Cortisporin?
|
Bacitracin, Neomycin, Polymyxin B, and Hydrocortisone
|
|
|
Cortisporin Indications?
|
Opthalmic oitment for prevention and treatment of susceptible inflammatory conditions where bacterial infection (or risk of infection) is present
|
|
|
Cortisporin dosing?
|
Ophthalmic ointment: Instill 1/2 inch ribbon to inside of lower lid every 3-4 hours until improvement occurs.
|
|
|
Caladryl?
|
Pramoxine Hydrochloride (Topical)
|
|
|
Cosopt?
|
Dorzolamide and Timolol
|
|
|
Cosopt indications?
|
Treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma
|
|
|
Cosopt dosing?
|
Instill 1 drop in affected eye(s) twice daily
|
|
|
Diflucan indiactions?
|
Treatment of candidiasis (vaginal, oropharyngeal, esophageal, urinary tract infections, peritonitis, pneumonia, and systemic infections); cryptococcal meningitis; antifungal prophylaxis in allogeneic bone marrow transplant recipients
|
|
|
Diflucan MOA?
|
Interferes with fungal cytochrome P450 activity (lanosterol 14-α-demethylase), decreasing ergosterol synthesis (principal sterol in fungal cell membrane) and inhibiting cell membrane formation
|
|
|
Diflucan dosing?
|
The daily dose of fluconazole is the same for both oral and I.V. administration (200-800 mg daily) depending on severity of infection
|
|
|
Doxycycline MOA?
|
ActionInhibits protein synthesis by binding with the 30S and possibly the 50S ribosomal subunit(s) of susceptible bacteria; may also cause alterations in the cytoplasmic membrane
|
|
|
Doxycyckline DOC?
|
Borrelia burgdorferi
Chlamydophila pneumoniae Ehrlichia Species Rickettsia rickettsii |
|
|
Erythromycin?
|
Akne-Mycin; E.E.S.; Ery-Tab; Eryc [DSC]; Eryderm [DSC]; Erygel [DSC]; EryPed; Erythro-RX; Erythrocin; PCE; Romycin
|
|
|
Erythromycin spectrum and DOC?
|
GRAM-NEGATIVE
Campylobacter jejuni; Bartonella henselae or quintana; Bordetella pertussi; Chlamydia trachomatis; Chlamydophilia; Mycoplasma pneumoniae |
|
|
Erythromycin MOA?
|
Macrolide: binds to the 50S ribosomal subunit resulting in blockage of transpeptidation
|
|
|
Debrox?
|
Carbamide Peroxide
|
|
|
Debrox indications?
|
Relief of minor inflammation of gums, oral mucosal surfaces, and lips including canker sores and dental irritation; emulsify and disperse ear wax
|
|
|
Debrox dosing?
|
Oral solution (should not be used for >7 days): Apply several drops undiluted on affected area 4 times/day after meals and at bedtime; expectorate after 2-3 minutes or place 10 drops onto tongue, mix with saliva, swish for several minutes, expectorate
|
|
|
Erythromycin oral dosing?
|
250-500 mg every 6-12 hours
|
|
|
Mycolog II
|
Nystatin and Triamcinolone
|
|
|
Mycolog II indications?
|
Treatment of cutaneous candidiasis
|
|
|
Mycolog II dosing?
|
Topical: Apply sparingly 2-4 times/day
|
|
|
Desitin?
|
Vitamins A and D (Topical)
|
|
|
Desitin indications?
|
Vitamins A and D, in a suitable cream or ointment base, is used topically as a protectant and/or emollient for various minor dermatologic conditions including diaper rash, chafed skin, abrasions, and minor burns.
|
|
|
Nystatin indications?
|
Treatment of susceptible cutaneous, mucocutaneous, and oral cavity fungal infections normally caused by the Candida species
|
|
|
Nystatin dosing?
|
Oral candidiasis: Suspension (swish and swallow orally): 400,000-600,000 units 4 times/day
|
|
|
Nystatin MOA?
|
ActionBinds to sterols in fungal cell membrane, changing the cell wall permeability allowing for leakage of cellular contents
|
|
|
Lotrisone
|
Betamethasone and Clotrimazole
|
|
|
Lotrisone indications?
|
Topical treatment of various dermal fungal infections (including tinea pedis, cruris, and corpora in patients ≥17 years of age)
|
|
|
Lotrisone max dose?
|
Do not exceed 45 g cream/week or 45 mL lotion/week
|
|
|
Dramamine?
|
DimenhyDRINATE: H1 agonist
|
|
|
Eucerin?
|
Urea: Keratolytic agent to soften nails or skin; OTC: Moisturizer for dry, rough skin
|
|
|
Fungi-Nail?
|
Treatment of athlete's foot (tinea pedis); ringworm (except nails and scalp
|
|
|
Ivy-Dry?
|
Zinc Acetate (2%), Benzyl Alcohol (10%).
|
|
|
Lumigan?
|
Bimatoprost: Synthetic analog of prostaglandin, decreases intraocular pressure by increasing the outflow of aqueous humor. Also enhances eyelash growth.
|
|
|
Patanol?
|
Olopatadine: Ophthalmic H1-antagonist; inhibits release of histamine from mast cells.
|
|
|
Timoptic?
|
Timolol: Beta-1 and beta-2 receptor blocker. Reduces intraocular pressure and outflow of aqueous humor
|
|
|
Tobradex?
|
Tobramycin and Dexamethasone: Antibiotic/Corticosteroid, Ophthalmic
|
|
|
Travatan?
|
Travoprost: Selective FP prostanoid receptor agonist. Lowers intraocular pressure by increasing outflow from trabecular meshwork.
|
|
|
Triamcinolone Acetonide?
|
Anti-inflammatory Agent; Corticosteroid, Topical
|
|
|
Valtrex?
|
Valacyclovir. Prodrug: Active form inhibits DNA synthesis and viral replication by competing with deoxyguanosine triphosphate for viral DNA polymerase and being incorporated into viral DNA
|
|
|
Valtrex dosing?
|
-Herpes labialis (cold sores): Oral: 2 g twice daily for 1 day.
-Genital herpes: Initial episode: 1 g twice daily for 10 days -Recurrent episode: 500 mg twice daily for 3 days |
|
|
Xalatan?
|
Latanoprost: Prostaglandin F2-alpha analog believed to reduce intraocular pressure by increasing the outflow of aqueous humor.
|
|
|
Zovirax?
|
Acyclovir: Triphosphate form inhibits DNA synthesis and viral replication by competing with deoxyguanosine triphosphate for viral DNA polymerase and being incorporated into viral DNA.
|
|
|
Zovirax dosing?
|
200-800 mg every 4 hours (5 times/day) for 7-10 days
|
|
|
Zithromax?
|
Azithromycin: Macrolide antibiotic
|
|
|
Zithromax MOA?
|
Binds bacterial 50S ribosomal subunit resulting in blockage of transpeptidation
|
|
|
Zithromax spectrum?
|
S. pyogenes; Chlamydophila pneumoniae, C. trachomatis, M. catarrhalis, H. influenzae, S. aureus, S. pneumoniae, Mycoplasma pneumoniae, and C. psittaci.
|
|
|
Zithromax dosage forms?
|
250 mg, 500 mg, 600 mg
|
|
|
Zithromax AEs >10%?
|
Diarrhea, nausea
|
|
|
Keflex?
|
Cephalexin: Cephalosporin (First Generation)
|
|
|
Keflex Drug of Choice indications?
|
Impetigo
Mastitis Osteomyelitis, Diabetic Foot Pharyngitis Skin and Soft Tissue |
|
|
Kelflex dose range?
|
Oral: 250-1000 mg every 6 hours (maximum: 4 g/day
|
|
|
Macrodantin?
|
Nitrofurantoin: Antibiotic, Miscellaneous
|
|
|
Macrodantin MOA?
|
Inhibits several bacterial enzyme systems (including acetyl coenzyme A) interfering with metabolism and possibly cell wall synthesis
|
|
|
Microdantin indications?
|
Prevention and treatment of urinary tract infections caused by susceptible strains of E. coli, S. aureus, Enterococcus, Klebsiella, and Enterobacter
|
|
|
Microdantin doses?
|
Oral: 50-100 mg/dose every 6 hours; administer for 7 days or at least 3 days after obtaining sterile urine
|
|
|
Phenazopyridine?
|
Urinary analgesic
|
|
|
Lamisil?
|
Terbinafine: Onychomycosis of the toenail or fingernail due to susceptible dermatophytes; treatment of tinea capitis
|
|
|
Lamisil dosing?
|
Fingernail: 250 mg daily for up to 6 weeks; may be given in 2 divided doses
Toenail: 250 mg daily for 12 weeks; may be given in 2 divided doses |
